ACCUSTEM SCIENCES, INC.

Andere talen AccuStem Sciences, Inc.

Aandelen

ACUT

US00444A1016

Beurs gesloten - OTC Markets Andere beurzen 19:25:18 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,35 ^USD	-25,52%		+26,35%	-44,06%

20/05	AccuStem Sciences, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
22/03	AccuStem Sciences, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	17-07-23
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	09-06-23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06-06-23
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	31-05-23
Accustem Sciences Inc. Appoints Sean McDonald to Its Board of Directors	16-11-22
Accustem Sciences Inc. Appoints Wendy Blosser as Director to Serve on the Board	05-04-22
AccuStem to Build Corporate Headquarters in Phoenix, Arizona	04-03-22
AccuStem Sciences, Inc. Appoints New Executive Leadership Team	04-03-22
AccuStem Sciences, Inc. Appoints Wendy Blosser as Chief Executive Officer	04-03-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.

PROFITEER NU